Preoperative Comorbidity and Mortality in Pediatric Liver Transplantation Recipients: A Population-Based Cohort Study
Yu-Jui Hsiao1, Fu-Chao Liu1,2, Hsiu-Pin Chen1,2
1Department of Anesthesiology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Insights
Pediatric liver transplant recipients with heart disease face the highest mortality risk. Overall, pediatric liver transplant survival rates are higher than in adults.
Area of Science:
- Hepatology
- Pediatric Surgery
- Transplant Immunology
Background:
- Liver transplantation (LT) is a life-saving procedure for end-stage liver disease.
- Understanding risk factors for mortality in pediatric LT recipients is crucial for improving outcomes.
- Preoperative comorbidities can significantly impact post-transplant survival.
Purpose of the Study:
- To investigate preoperative comorbidities as risk factors for mortality in pediatric liver transplant recipients.
- To compare survival rates between pediatric and adult liver transplant patients.
Main Methods:
- A large, population-based study utilizing Taiwan's National Health Insurance Research Database (NHIRD).
- Inclusion of 2,938 liver transplant recipients (1998-2012), with a focus on 341 pediatric patients (<18 years).
- Extraction of comorbidity data using ICD-9-CM codes and follow-up to study endpoint or death.
Main Results:
- Pediatric patients with heart disease demonstrated the highest risk of mortality post-LT.
- Overall survival rates were significantly different between pediatric and adult LT recipients (log-rank p = 0.002).
- 41 deaths occurred among pediatric recipients during a median follow-up of 6.1 years.
Conclusions:
- Cardiac disease is a significant risk factor for mortality in pediatric liver transplant recipients.
- Pediatric liver transplant recipients exhibit higher survival rates compared to adult recipients.
- Identifying and managing preoperative comorbidities is essential for enhancing pediatric LT outcomes.
Objective:
The purpose of this large, population-based study was to investigate preoperative comorbidities as risk factors of mortality in pediatric liver transplant recipients.
Methods:
A total of 2,938 patients who underwent liver transplantation (LT) surgery from 1998 through 2012 in Taiwan were enrolled in this study. Based on the International Classification of Disease, 9th Revision, Clinical Modifi cation (ICD-9-CM) codes, basic information regarding medical comorbidities was extracted from the National Health Insurance Research Database (NHIRD).
Results:
All patients were followed to the endpoint of the study or until death. The study enrolled 2,597 adult (≥ 18 years old) and 341 pediatric (< 18 years old) liver transplant recipients. The median age for the pediatric cohort was 1.88 years (interquartile range = 0.92-5.42 years). Four hundred and twenty-eight deaths occurred after LT in the total population, including 41 children. The median follow-up period was 6.1 years (interquartile range = 2.5-9.7 years) in pediatric liver transplant recipients. Pediatric patients with heart disease exhibited the highest risk of mortality. Further, during the entire study period of 14.5 years, patient survival rates were signifi cantly different (log-rank p = 0.002) for patients younger than 18 years and those older than 18 years.
Conclusion:
Cardiac disease is an important risk of mortality in pediatric LT. These fi ndings confi rm that the survival rate of LT is higher in pediatric patients than in adult patients.
Related Concept Videos
What is Population Genetics?
Conservation of Small Populations
Population Growth
What are Populations and Communities?
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution


